Products
Sherpa
Drafter
Reviewer
Researcher
Audiences
MedTech
Startups
Consultants
Guideways.ai
About us
Technology
FAQ
Trust
News & Insights
Contact us
Location: DotSlash
Date: 12 February 2026
17:30 – 18:00 Arrival, welcoming guests
18:00 – 20:00 Launch event including
20:00 – 21:00 Reception with drinks and bites
A good pilot can land a plane in a storm, an excellent pilot knows how to fly around bad weather
Your starting point for classification, predicates, pathways, guidances, standards and controls. Sherpa turns a plain-language device description into an underpinned regulatory strategy.
FDA Reviewer helps you find gaps and inconsistencies in regulatory submissions before regulators do, reducing the risk of delays, questions and rework.
FDA Researcher delivers deep, evidence-backed regulatory answers without the need to manually search and cross-reference dozens of documents.
Guideways Explorers receive early access to Guideways before our first commercial release of the platform and will continue to receive early access to new capabilities as the platform expands and new regulatory areas are added.
Early access to the Guideways platform features before public availability
Invitations to expert sessions and community events
A direct channel to influence future releases and features
Expanded usage allocation, including 4 additional devices across FDA Sherpa, FDA Reviewer and FDA Researcher, and 20 user seats